Abstract
Antibody fragment crystallizable region (Fc) glycosylation critically modulates immune signaling, yet characterization of glycosylation beyond the immunoglobulin G (IgG) isotype remains limited. Here, we present the first site-specific glycoprofiling of immunoglobulin A (IgA) and immunoglobulin M (IgM) in elderly individuals with tuberculosis (TB), a population particularly susceptible to disease reactivation. Using dual-enzyme digestion and targeted LC-MS/MS analysis, we quantified Fc glycosylation of IgG, IgA, and IgM in plasma from 20 patients with active TB (ATB), 18 with latent TB infection (LTBI), and 20 controls. Consistent with previous studies, IgG1 and IgG2 in ATB displayed reduced galactosylation and elevated fucosylation compared with LTBI. Extending the analysis to other isotypes, we identified analogous alterations in IgA and IgM. ATB samples showed reduced digalactosylation and increased monogalactosylation at IgA1/2-N144/131, indicating a shift toward agalactosylation. In IgM, decreased galactosylation at N171, N332, and N395, increased agalactosylation at N563, and increased fucosylation and sialylation at N71 were observed in ATB relative to LTBI and controls. Integrating 18 significantly altered glycosylation traits across all three Ig isotypes revealed coordinated humoral remodeling associated with active disease. Collectively, these findings indicate that IgA and IgM, like IgG, undergo infection-associated proinflammatory glycan remodeling, underscoring their overlooked roles in antibody-mediated immune modulation and providing a broader framework for understanding humoral responses in aging and chronic infection.